Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

U.S. patent covering novel CPC-111 formulation

Sep. 5, 1997

Warner-Lambert reports novel MMP inhibitors

Sep. 5, 1997

Celgene claims PDE/TNF/NFkappaB inhibitors

Sep. 5, 1997

Summary of azelnidipine preclinical data

Sep. 5, 1997

Fullerene derivative with vasorelaxant effects described by Japanese academics

Sep. 5, 1997

Spotlight on adenosine A1 receptor agonists

Sep. 4, 1997

DANAMI trial results presented

Sep. 4, 1997

Role of vitamin C in cardiovascular diseases investigated

Sep. 4, 1997

Lipoprotein(a): new insights into the process of atherosclerosis

Sep. 4, 1997

Large, long-term trial evaluates association between heart rate and mortality

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...